Elisabeth Heath, MD, FACP, explains the design and outcomes of the ACIS study from ASCO GU 2021

Dr. Heath, Chair, Genitourinary Oncology Multidisciplinary Team, Director, Prostate Cancer Research, Barbara Ann Karmanos Cancer Institute, Professor of Oncology, Wayne State University, explains the design and outcomes of the ACIS study evaluating the combination of apalutamide and abiraterone plus prednisone versus abiraterone plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)